Compare NEM & CI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEM | CI |
|---|---|---|
| Founded | 1916 | 1792 |
| Country | United States | United States |
| Employees | 17500 | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.9B | 79.0B |
| IPO Year | N/A | 2018 |
| Metric | NEM | CI |
|---|---|---|
| Price | $96.05 | $282.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 15 |
| Target Price | $122.08 | ★ $349.00 |
| AVG Volume (30 Days) | ★ 8.1M | 1.4M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | 0.97% | ★ 2.13% |
| EPS Growth | N/A | ★ 83.00 |
| EPS | N/A | ★ 6.26 |
| Revenue | N/A | ★ $274,900,000,000.00 |
| Revenue This Year | $28.85 | $5.91 |
| Revenue Next Year | $5.24 | $5.92 |
| P/E Ratio | ★ $19.39 | $45.03 |
| Revenue Growth | N/A | ★ 11.24 |
| 52 Week Low | $55.37 | $239.51 |
| 52 Week High | $134.88 | $338.89 |
| Indicator | NEM | CI |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 46.34 |
| Support Level | $94.68 | $280.76 |
| Resistance Level | $98.58 | $294.33 |
| Average True Range (ATR) | 3.71 | 6.25 |
| MACD | -0.50 | -1.16 |
| Stochastic Oscillator | 18.45 | 25.98 |
Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 11 mines and interests in two joint ventures in the Americas, Africa, Australia, and Papua New Guinea. The company is expected to sell roughly 5.3 million ounces of gold in 2026 from its continuing mines after selling six higher-cost, smaller mines following the Newcrest acquisition. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves, along with significant byproduct reserves at the end of December 2025.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.